Loading…
Marker Therapeutics, Inc. is projected to decline to $1.20 by 2027, a -1% move from its current price of $1.22. MRKR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.19 | $1.22 | $1.26 | +0.07% |
| Aug 6 | $1.17 | $1.22 | $1.27 | +0.13% |
| Aug 7 | $1.16 | $1.22 | $1.29 | +0.20% |
| Aug 8 | $1.15 | $1.22 | $1.30 | +0.27% |
| Aug 9 | $1.15 | $1.22 | $1.31 | +0.34% |
| Aug 10 | $1.14 | $1.22 | $1.32 | +0.40% |
| Aug 11 | $1.13 | $1.23 | $1.32 | +0.47% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.13 | $1.23 | $1.32 | +0.47% |
| Week 2 | $1.10 | $1.23 | $1.37 | +0.94% |
| Week 3 | $1.08 | $1.24 | $1.41 | +1.42% |
| Week 4 | $1.06 | $1.24 | $1.45 | +1.90% |
| Week 5 | $1.05 | $1.25 | $1.48 | +2.38% |
| Week 6 | $1.04 | $1.25 | $1.52 | +2.86% |
| Week 7 | $1.03 | $1.26 | $1.55 | +3.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Marker Therapeutics, Inc. is a healthcare company focused on clinical-stage immuno-oncology. It develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.
The company’s multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets.
Marker Therapeutics, Inc. was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics was founded in 1999 and is headquartered in Houston, Texas.
Marker Therapeutics, Inc. (MRKR) is a healthcare biotechnology company focused on immuno-oncology. The stock is currently trading at $1.11, with a market capitalization of $18.51M, and it holds a rank of 4888.
The price outlook is mixed in the near term and more constructive in later years according to the provided forecast. In 2026, the forecast shows a neutral stance with min $1.11, avg $1.11, max $1.43. The trajectory shifts toward higher averages and bullish momentum into the 2029‑2030 window and beyond, with 2030’s average price at $1.55.
A major floor 39.6% below — a decisive break under it would weaken the trend.
The nearest floor, 9.0% below — buyers have tended to step in here.
The nearest ceiling, 37.7% above — a clean break opens room to run.
A major ceiling 53.8% above — clearing it would confirm fresh momentum.
Key MRKR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MRKR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.15 | Buy | $1.15 | Buy |
| MA 10 | $1.20 | Buy | $1.21 | Buy |
| MA 20 | $1.34 | Sell | $1.28 | Sell |
| MA 50 | $1.39 | Sell | $1.36 | Sell |
| MA 100 | $1.41 | Sell | $1.40 | Sell |
| MA 200 | $1.40 | Sell | $1.45 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 30.67 | Neutral |
| Stoch RSI (14) | 13.63 | Buy |
| CCI (20) | -99.58 | Neutral |
| Williams %R (14) | -93.94 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -19.86 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 6.06 | Buy |
| TRIX (15) | -0.53 | Sell |
| Awesome (5,34) | -0.21 | Sell |
| Ultimate (7,14,28) | 22.54 | Buy |
| Momentum (10) | -0.18 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 1.10 | Buy |
| ADX (14) | 24.98 | Sell |
| ATR (14) | 0.04 | Info |
The 30‑day technical picture is NEUTRAL, with RSI14 at 30. This suggests limited downside momentum in the near term.
Key technical levels include a support at $1.11 and a resistance at $1.68. The 30‑day price range is $0.9057 to $1.36. The 50‑day and 200‑day simple moving averages are both at $1.40, indicating a flat near‑term trend around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.11 | $1.22 | $1.56 | 0% | Neutral | |
| $0.9549 | $1.20 | $1.61 | -1% | Neutral | |
| $1.00 | $1.30 | $1.81 | +7% | Neutral | |
| $1.23 | $1.64 | $2.35 | +34% | Bullish | |
| $1.26 | $1.72 | $2.53 | +41% | Bullish | |
| $1.22 | $1.70 | $2.56 | +40% | Bullish | |
| $1.17 | $1.66 | $2.56 | +36% | Bullish | |
| $1.19 | $1.72 | $2.69 | +41% | Bullish | |
| $1.33 | $1.96 | $3.12 | +61% | Bullish | |
| $1.46 | $2.17 | $3.51 | +78% | Bullish | |
| $1.67 | $2.68 | $4.63 | +120% | Bullish | |
| $2.65 | $4.83 | $9.15 | +296% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.11 | $1.22 | $1.45 | +0.00% |
| September 2026 | $1.06 | $1.26 | $1.53 | +3.15% |
| October 2026 | $1.09 | $1.30 | $1.60 | +3.06% |
| November 2026 | $1.05 | $1.26 | $1.57 | -2.53% |
| December 2026 | $1.03 | $1.24 | $1.56 | -1.83% |
Click any year to see its month-by-month MRKR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MRKR to range from $1.11 to $1.56 through 2026. The $1.22 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MRKR price prediction for 2027 points to an average of $1.20 (low $0.9549, high $1.61) — a potential decline of -1% on today's $1.22. Price action looks broadly range-bound.
In 2028, MRKR is projected to trade between $1.00 and $1.81, averaging $1.30 — a potential gain of +7% from today's $1.22. That is up +8% on the projected 2027 average. A consolidation phase looks the most probable path here.
Marker Therapeutics, Inc.'s 2029 outlook centres on $1.64, within a $1.23 to $2.35 range. That is up +26% on the projected 2028 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2030, MRKR could reach as high as $2.53, with a base case around $1.72 and support toward $1.26 — roughly +41% from $1.22. Buyers look set to stay in control over this stretch.
Expect MRKR to range from $1.22 to $2.56 through 2031. The $1.70 average target implies a +40% move from current prices. That is -1% versus the projected 2030 average. Momentum favours further upside here.
The MRKR price prediction for 2032 points to an average of $1.66 (low $1.17, high $2.56) — a potential gain of +36% on today's $1.22. Buyers look set to stay in control over this stretch.
In 2033, MRKR is projected to trade between $1.19 and $2.69, averaging $1.72 — a potential gain of +41% from today's $1.22. That is up +3% on the projected 2032 average. Momentum favours further upside here.
Marker Therapeutics, Inc.'s 2034 outlook centres on $1.96, within a $1.33 to $3.12 range. That is up +14% on the projected 2033 average. That marks a +61% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MRKR could reach as high as $3.51, with a base case around $2.17 and support toward $1.46 — roughly +78% from $1.22. Momentum favours further upside here.
Expect MRKR to range from $1.67 to $4.63 through 2040. The $2.68 average target implies a +120% move from current prices. That is up +23% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MRKR price prediction for 2050 points to an average of $4.83 (low $2.65, high $9.15) — a potential gain of +296% on today's $1.22. Momentum favours further upside here.
Investing $1,000 in MRKR today (≈ 819.672131 MRKR) could be worth
$3,956.85
+$2,956.85 (+296%) by 2050 · US Dollar
Based on the average projected MRKR price of $4.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MRKRwould be worth at today's price.
$1,000 invested in MRKR on Jul 31, 2025 (≈ 714.285726 MRKR) would be worth
$871.43
-$128.57 (-12.9%) today · 0.87× · US Dollar
Based on a MRKR entry price of $1.4 vs. today's $1.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.22 | $1,000 | -0.0% |
| 1 month ago | $1.45 | $841.38 | -15.9% |
| 3 months ago | $1.46 | $835.62 | -16.4% |
| 6 months ago | $1.71 | $713.45 | -28.7% |
| 1 year ago | $1.4 | $871.43 | -12.9% |
| All time (5.0y) ago | $21.2 | $57.55 | -94.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MRKR forecast.
Our base-case forecast reaches $2.40 around 2040.
Implied market cap at $2.40: $40.02M
The multi‑year forecast shows a bullish trajectory beginning later in the decade. In 2029, the average price is $1.49 with ROI 34.1. By 2030, the average is $1.55 with ROI 39.8, and the sentiment remains BULLISH through the mid‑decade, with 2031 at $1.52 (ROI 36.7), 2032 at $1.50 (ROI 35.1), and 2033 at $1.53 (ROI 38).
By 2034 the average price rises to $1.73 (ROI 56) and by 2035 reaches $1.95 (ROI 75.7), with broader bullish momentum continuing into 2040 at $2.37 (ROI 113.2) and 2050 at $4.28 (ROI 285.3). The forecast also shows the max price path rising, with 2040 max $4.16 and 2050 max $8.29. The asset exhibits higher volatility in this horizon, reflected by an annualized volatility of 60%.
These figures are estimates and not guarantees.
Tap a question to reveal the answer.
2029 avg is $1.49, with min $1.11 and max $2.16; ROI 34.1; sentiment is NEUTRAL.
Forecasts show neutral sentiment in 2026, turning bullish later with 2029–2050 average prices climbing to $1.49–$4.28 and max values up to $8.29, but these are estimates and not guarantees; risk remains as indicated by volatility.
Yes. The forecast max by 2050 is $8.29, which exceeds $5.
2026 min $1.11, avg $1.11, max $1.43; ROI 0; sentiment NEUTRAL.
Annualized volatility is 60%, indicating substantial potential price fluctuation over the forecast horizon.
Marker Therapeutics, Inc. Community Discussion
0Share your Marker Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.